000 01417 a2200409 4500
005 20250515120447.0
264 0 _c20080610
008 200806s 0 0 eng d
022 _a1538-7445
024 7 _a10.1158/0008-5472.CAN-07-5271
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaguire, Maria
245 0 0 _aMDM2 regulates dihydrofolate reductase activity through monoubiquitination.
_h[electronic resource]
260 _bCancer research
_cMay 2008
300 _a3232-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCells, Cultured
650 0 4 _aDown-Regulation
650 0 4 _aEnzyme Activation
650 0 4 _aFolic Acid Antagonists
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMethotrexate
_xpharmacology
650 0 4 _aProtein Binding
650 0 4 _aProto-Oncogene Proteins c-mdm2
_xchemistry
650 0 4 _aRING Finger Domains
_xphysiology
650 0 4 _aTetrahydrofolate Dehydrogenase
_xmetabolism
650 0 4 _aUbiquitination
700 1 _aNield, Paul C
700 1 _aDevling, Timothy
700 1 _aJenkins, Rosalind E
700 1 _aPark, B Kevin
700 1 _aPolański, Radoslaw
700 1 _aVlatković, Nikolina
700 1 _aBoyd, Mark T
773 0 _tCancer research
_gvol. 68
_gno. 9
_gp. 3232-42
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-07-5271
_zAvailable from publisher's website
999 _c17947258
_d17947258